Does Benzodiazepine Tapering Cause Weight Gain or Weight Loss?

Does a benzodiazepine taper make people gain weight?

Sometimes, yes. More often, the scale moves the other way. Professor C. Heather Ashton answered the question in Chapter III of the Ashton Manual, in the section on digestive problems.

Considerable loss of weight, of eight to ten pounds or more, sometimes occurs in withdrawal, she wrote, while some people gain weight. In her words, weight changes “are not severe enough to worry about and normal weight is soon regained after withdrawal.”

That is close to the whole of what can be said with confidence. The evidence on benzodiazepines and body weight is thin, and most of what the internet adds to it is confident, detailed, and made up.

Dr. Mark Leeds, an osteopathic physician who supervises benzodiazepine tapers in Fort Lauderdale, Florida, hears the weight question often, and usually at the first visit. Patients want to know whether the drug is doing it, whether the taper is doing it, and what to change. So, where do the changes come from?

The weight question often arrives wrapped in a bigger mistake.

Many people asking about weight during a taper have already been told, by a relative or an emergency room doctor, that they have a drug problem. They took a medication exactly as prescribed, often for years, and now the body objects when the dose goes down. That is not a habit, and it is not a weakness.

Physical dependence is not addiction. It is the nervous system’s adjustment to a drug that was there every day, and it happens to people who never took one more pill than the label allowed. Benzodiazepines strengthen gamma-aminobutyric acid (GABA), the brain’s main calming signal, and with steady use the brain turns down its own supply to compensate.

When the dose falls, the brain is left short of calm until it readjusts, and readjustment is slow. That is why the taper is slow, and the same imbalance sits behind nearly every weight change below.

Why does weight move at all during a taper?

Because nearly everything that sets a person’s weight is disturbed at once. Professor Ashton’s own suggestion for the weight loss was a rebound effect on appetite, since, as the Manual notes, benzodiazepines have been shown to increase appetite in animals. Beyond that lies clinical experience, which varies.

The drivers Dr. Leeds sees are ordinary ones. Sleep breaks up, and a person who is awake at three in the morning eats differently from one who is not. Anxiety returns for a while, and some people cannot face food when anxious while others cannot stop.

Activity changes too. Years of sedation kept some patients on the couch, and withdrawal symptoms keep others there, so the same taper raises one person’s activity and lowers another’s. Add nausea, bloating, and a gut that has lost its rhythm, and the scale has plenty of reasons to wander.

None of those reasons is the drug reaching into a fat cell. The weight follows sleep, appetite, movement, and the gut. It does not lead them.

Benzo belly is a gut symptom, not a fat problem.

Patients in the withdrawal community call it benzo belly. The Ashton Manual’s Chapter III symptom list names the parts: nausea, vomiting, diarrhea, constipation, pain, distension, and difficulty swallowing. Distension is the one that shows in the mirror and on the scale, and it is mostly gas, not tissue.

Chapter III also notes that gastrointestinal symptoms may be prolonged after withdrawal, usually in people who had digestive trouble before the benzodiazepine. A gut that takes months to settle after the last dose is not proof that the taper failed. It is the last system to relearn its rhythm.

While a bloated abdomen is miserable, it does respond to plain measures: smaller meals, more of them, and foods a person already tolerates. Anything beyond that belongs in a conversation with your doctor, not in a rule from a website.

The bathroom scale is a poor instrument for steering a taper.

Think of the fuel gauge in a car parked on a steep driveway. The needle reads high with the nose uphill and low with the nose downhill, though the fuel has not changed. A scale during a taper behaves the same way, tilted by a night of poor sleep, a bloated gut, a day of nausea, or a week of eating for comfort.

While this is not a perfect analogy, the lesson holds. Rapid weight loss or gain is sometimes offered as a sign that a taper is too aggressive. The Ashton Manual lists appetite and weight change among ordinary withdrawal symptoms and tells the reader not to worry about it, and nowhere does it make the scale a measure of the taper’s pace. The pace is judged by how a person feels, and a weekly weigh-in adds anxiety without adding information.

So, park the scale. Weigh yourself no more often than you did before the taper, and tell your doctor about the number rather than acting on it.

Should weight change ever speed up a taper?

No, and the reason is printed on the label. The 2020 boxed-warning update from the United States Food and Drug Administration (FDA) states that stopping a benzodiazepine suddenly, or cutting the dose quickly after continued use, can bring on life-threatening withdrawal reactions, seizures among them, and it calls for a gradual taper instead. Call emergency services for a seizure or any medical emergency.

A faster taper does not make the scale behave. It makes everything else misbehave, sleep and appetite and gut included.

Unfortunately, some people are still told to hurry, by a relative who wants it over or a treatment center on an insurance calendar. Fortunately, the Manual is on the patient’s side. It suggests reductions of up to one tenth of the dose at each step, with the person tapering in control of the pace. Professor Ashton was blunt about the rest: there is no need to hurry withdrawal, and no doctor should impose a deadline.

The Maudsley Deprescribing Guidelines refine the shape, with each reduction smaller than the last as the dose gets lower, because the last milligrams carry more of the drug’s effect than the first. That shape takes months, sometimes longer, with holds whenever symptoms ask for one. Weight is discussed at those holds. It never sets them.

What about Valium, Xanax, and Klonopin?

Valium, or diazepam, has the one different story here, and it has nothing to do with weight. Table 1 in the Manual’s opening chapter gives diazepam a half-life of 20 to 100 hours, and its active metabolite a half-life of up to 200 hours. Chapter II builds the crossover taper on that slow elimination: moving from a short-acting benzodiazepine onto diazepam gives a smooth, gradual fall in blood level and tablets small enough to cut in tiny steps. The slow exit is the whole point.

Xanax, or alprazolam, and Klonopin, or clonazepam, sit in the same table with shorter half-lives, which change the pattern of between-dose symptoms, not the weight picture. Sedation lowers activity, and appetite can move either way on any of them. The answer to the weight question is the same on all three.

What helps, in plain words.

Eat on a schedule even when appetite has gone, since small meals sit better than skipped ones. Keep protein in most meals, keep fluids up on the days nausea wins, and choose the foods your gut has already approved. No diet treats withdrawal, and nothing here should be mistaken for one.

Move a little most days. Chapter III of the Manual, in its section on diet, fluids, and exercise, recommends regular moderate exercise during withdrawal, and the word that matters is moderate. A walk that leaves a person calmer is the right dose, and a workout that leaves them shaking for two days is not.

Keep a bedtime and a wake time, even on nights that go badly, since sleep sits behind most of the eating changes. And, be fair to yourself about the number on the scale. Nobody gains or loses ten pounds in a taper through weakness of will.

Tell your doctor if weight falls quickly with vomiting, if fluids will not stay down, or if eating has stopped for more than a day or two. If low mood during a taper ever turns into thoughts of suicide, call or text 988, the Suicide and Crisis Lifeline, or call emergency services. Those are not weight problems, and they are not to be waited out.

How Dr. Leeds handles the weight question.

Dr. Leeds’ practice is one physician, seeing patients by telemedicine throughout Florida from Fort Lauderdale, on a concierge basis rather than through insurance. Each medically supervised benzodiazepine taper follows the Ashton Manual’s shape, with a crossover taper to diazepam where it helps and reductions that shrink as the dose falls, over months and sometimes longer.

The patient sets the pace, and holds are taken when symptoms ask for them. Informed consent means the risks come first, the alternatives stay on the table, there is an exit plan from the start, and the right to decline holds at every visit.

When weight comes up, and it often does, it is treated as a symptom of disturbed sleep, appetite, and digestion, never as a verdict on the taper. Anyone in Florida who wants a benzodiazepine or z-drug taper supervised this way can Contact Dr. Leeds through the practice’s contact form.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.